Mass Tort Report

Keeping you up to date with the
world of mass torts.

by Attorney Jeff Keiser

Your subscription could not be saved. Please try again.
Your subscription has been successful.

* I agree to receive emails, text messages, and phone calls regarding my inquiry, which may be considered advertising material. Emails, text messages, and phone calls may be automatically generated using the information from the above form to better coordinate communication. I understand my consent to this is not necessary to obtain services from Legal Calls. MSG and Data Rates may apply.

Breaking: Bankruptcy Denied: What the Latest Blow to J&J Means for Talc Litigation
April 2, 2025
A federal judge rejected Johnson & Johnson’s third attempt to settle talc-related cancer claims through bankruptcy — a major win for plaintiffs. J&J will not appeal and is now preparing to fight the lawsuits in court, signaling a shift from mass settlement to full-scale litigation.
READ MORE
Breaking News: Bayer hit with $2 billion Roundup verdict in Georgia cancer case
Mar 24, 2025
Bayer was ordered by a jury in the U.S. state of Georgia to pay about $2.1 billion to a plaintiff who claimed the company's Roundup weed killer caused his cancer, the plaintiff's law firms said late on Friday. An interesting detail is that John Barnes, the plaintiff, developed Non-Hodgkin's...
READ MORE
Mass Torts in 2025: The Legal Firestorm That Just Won't Quit
Mar 11, 2025
If you thought 2025 would be the year corporate defendants finally caught a break from mass tort litigation, you would be sorely mistaken. The world of mass torts is more intense than ever, with pharmaceutical companies, medical device manufacturers, social media giants, and other major industries embroiled in lawsuits that could redefine their futures.
READ MORE
Roundup with Confirmed NHL Diagnosis - Part 2
Mar 5, 2025
We're offering Roundup Claimants with a confirmed Non-Hodgkin's Lymphoma diagnosis, and we've been getting great feedback from clients. Each claimant is guaranteed to have NHL and comes with proof of diagnosis. The primary qualifying diagnosis for Roundup claims is Non-Hodgkin's Lymphoma, along with many subtypes of this cancer. A list of the subtypes is below.
READ MORE
Roundup with Confirmed NHL Diagnosis
Feb 26, 2025
We're offering Roundup Claimants with a confirmed Non-Hodgkin's Lymphoma diagnosis, and we've been getting great feedback from clients. Each claimant is guaranteed to have NHL and comes with proof of diagnosis. We've been doing Roundup for several years now, and here are the best practices we follow stop Roundup fraud cold without turning away legitimate claimants.
READ MORE
Martinez v. Big Food: A Case That Could Put Your Snacks on Trial
Feb 20, 2025
Let's talk about Martinez v. Kraft Heinz, filed in the Philadelphia County Court of Common Pleas. This case doesn't just ask whether ultra-processed foods (UPFs) are bad for you—it asks whether the companies who make them deserve to pay for decades of damage to public health. Spoiler: It's looking like the snack aisle might need a legal defense fund.
READ MORE
Legal Crossroads: How State Supreme Courts Are Reshaping Child Abuse Lawsuits
Feb 13, 2025
The landscape of child sexual abuse litigation is evolving rapidly, placing plaintiff lawyers at a crossroads. Some states are opening the doors wide for survivors seeking justice, while others are slamming them shut. The key question for attorneys investing in these cases is straightforward: where is the best place to dedicate time, money, and effort? Because, while the legal system is rooted in principle, it is also undeniably about strategy.
READ MORE
Emerging MDLs - Paraquat, Hair Relaxer, NEC & more
Feb 11, 2025
Mass tort filings continued to rise in 2024, with some cases seeing explosive growth. The Hair Relaxer litigation now includes over 8,000 claims alleging links to ovarian and uterine cancers. The Paraquat litigation, tied to Parkinson's disease, has reached 5,825 cases. Bard PowerPort cases surged from 150 at the beginning of the year to nearly 900 by January 2025, centered on claims of device fractures and migrations.
READ MORE
Talc, 3M, Camp L. & Mass Tort News
Feb 6, 2025
The mass tort world has been a rollercoaster over the past year—complete with nail-biting twists, billion-dollar breakthroughs, and a few unexpected delays that had everyone reaching for the stress ball. While some setbacks tried to steal the spotlight, 2024 delivered big wins for plaintiffs, and 2025 is already shaping up to be a sequel worth watching. From historic settlements to emerging MDLs, the drama continues.
READ MORE
BioZorb Litigation: A Guide for Plaintiff Lawyers
Jan 28, 2025
The BioZorb litigation offers a significant opportunity for plaintiff lawyers. As we consider their involvement in this case, it is crucial to consider the intricacies of the litigation, the potential plaintiff pool, the possibility of an MDL, and the approach of the currently presiding judge. This litigation might just be the first big case of 2025 for plaintiff lawyers - nationwide.
READ MORE
Depo-Provera - Potential Payouts
Dec 23, 2024
Understanding the evolving landscape of the Depo-Provera litigation can feel overwhelming, but it doesn't have to be. By comparing Depo-Provera litigation to other notable cases, lawyers can identify common hurdles, legal frameworks, and potential settlement trends to guide strategy.
READ MORE
Roundup with Confirmed NHL Diagnosis
Dec 19, 2024
We're offering Roundup Claimants with a confirmed Non-Hodgkin's Lymphoma diagnosis, and we've been getting great feedback from clients. Each claimant is guaranteed to have NHL and comes with proof of diagnosis. We've been doing Roundup for several years now, and here are the best practices we follow stop Roundup fraud cold without turning away legitimate claimants.
READ MORE
Oxbryta Litigation: Examining the Legal Challenges and Implications of the Recent Recall
December 11, 2024
Oxbryta Litigation Deep Dive The pharmaceutical industry is currently facing significant legal scrutiny following the recall of Oxbryta, a medication developed to treat sickle cell disease (SCD). Manufactured by Pfizer, Oxbryta was intended to alleviate the symptoms of SCD but has been linked to severe health complications, including increased risks of vaso-occlusive crises and death. …
READ MORE
Chemical Hair Straightener: Potential Payouts
December 5, 2024
Hair Straightener Potential Payouts A continued deep dive into Chemical Hair Relaxer Lawsuits from Legalcalls.com by Attorney Jeff Keiser. Estimating potential settlement amounts in the hair straightener litigation involves analyzing comparable product liability cases where plaintiffs alleged health issues due to consumer products. As of December 2024, the hair relaxer litigation is ongoing, with no …
READ MORE
Chemical Hair Relaxer Lawsuits: A Comprehensive Look at the Claims, Challenges, and Industry Impact
November 26, 2024
Claims, Challenges and Impact of Chemical Hair Relaxer Litigation A deep dive into Chemical Hair Relaxer Lawsuits from Legalcalls.com by Attorney Jeff Keiser. The hair relaxer litigation is shaping up to be one of the most significant legal battles in the cosmetics industry in history. This wave of lawsuits alleges that prolonged use of chemical …
READ MORE
Depo-Provera Litigation: Legal Challenges and Industry Implications
November 8, 2024
A Deep Dive Into Depo-Provera Litigation The Depo-Provera litigation has emerged as a pivotal legal battle that sheds light on pharmaceutical safety and corporate accountability. Below, we explore the history of Depo-Provera, the experiences of key plaintiffs, the challenges law firms face, and the broader implications for the pharmaceutical industry. Overview of Depo-Provera Approved by …
READ MORE
$2.2 Billion Zantac Settlement Breakdown
October 23, 2024
What You Need to Know – Zantac Settlement Update In a major development for one of the largest pharmaceutical litigations in recent history, GlaxoSmithKline (GSK) has agreed to pay up to $2.2 billion to settle approximately 80,000 state court lawsuits related to claims that its former heartburn medication, Zantac, caused cancer. by Attorney Jeff Keiser. …
READ MORE
Momentum, Potential and Challenges
October 10, 2024
Here’s Your October Mass Tort Report update from Legalcalls.com by Attorney Jeff Keiser. We know how busy life can get, so we’re here to help you stay ahead of the curve in the ever-changing world of legal marketing. Whether you’re looking for new cases to chase or a reliable source for leads on the classics, …
READ MORE
Settlements on the Horizon: What to Expect Before Year-End
September 20, 2024
Here’s Your September Mass Tort Report update – by Attorney Jeff Keiser. While nothing is set in stone, it feels like we may be heading toward some big news, potentially even before the year ends. Admittedly, I’ve been overly optimistic in the past (just ask anyone who knows me), but this time, the signs are …
READ MORE
Roundup Part 2: Detailed list of NHL Sub Types
September 17, 2024
We’re offering Roundup Claimants with a confirmed Non-Hodgkin’s Lymphoma diagnosis, and we’ve been getting great feedback from clients. Each claimant is guaranteed to have NHL and comes with proof of diagnosis. Part 2: Comments From Our Fulfillment Department We’ve been signing up Roundup claimants for several years now, so we asked our fulfillment department …
READ MORE
Roundup with Confirmed NHL Diagnosis
September 2, 2024
We’re offering Roundup Claimants with a confirmed Non-Hodgkin’s Lymphoma diagnosis, and we’ve been getting great feedback from clients. Each claimant is guaranteed to have NHL and comes with proof of diagnosis. Roundup Best Practices We’ve been doing Roundup for several years now, and here are the best practices we follow stop Roundup fraud cold …
READ MORE
Camp Lejeune Filing Deadline Looms & more
August 15, 2024
Mass Tort Report Update – by Attorney Jeff Keiser. August always feels like the end of Summer, and honestly, that can’t come soon enough. With unbearable heat, hurricane season, crowded ‘everywhere’, and everything else that comes with summer, I’m ready for things to cool off a bit. One thing is for sure – the mass …
READ MORE
Supreme Court
July 11, 2024
Mass Tort Report Update – by Attorney Jeff Keiser. After an exciting 4th of July weekend, we’re back for more mass tort news and updates. We hope you and family have returned with all your fingers and had some time to decompress a little. That part is important too. But now that we’re back, let’s dig …
READ MORE
Zantac is Back?
June 25, 2024
Zantac Update – by Attorney Jeff Keiser. Earlier this month (June 3), the Zantac litigation was revived through Delaware state courts. Zantac (as a nationwide MDL) was effectively killed by District Court Judge Robin Rosenberg back in 2022, when she held that plaintiffs’ causation experts did not pass evidentiary muster. That simple order simply eliminated …
READ MORE
Settlement Agreements Update
May 9, 2024
Settlement Agreements Update – by Attorney Jeff Keiser. We’ve been promising some big news in some of these cases for a few months, and today, there is a lot more going on than status conferences and Daubert hearings. We have settlement agreements to discuss, and maybe even a new case or two to start planning …
READ MORE
CPAP Settlement Reached
May 1, 2024
CPAP Settlement Update- by Attorney Jeff Keiser. Settlement Reached Big news in the CPAP case! A settlement has been reached between Philips and plaintiffs seeking personal injury damages for more than $1.1 billion. Philips refused to accept any responsibility for the product’s defects. This comes on the heels of another settlement in the case, …
READ MORE
First NEC Baby Formula Settlement
March 19, 2024
NEC Baby Formula Update – by Attorney Jeff Keiser. Damages Awarded The NEC Baby Formula cases have been quiet the last few months, but we have some fantastic news to share. Last Thursday (March 14, 2024), an Illinois jury awarded the first plaintiff to present their case a staggering $60 million in damages. Mead …
READ MORE
X
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Ad Network Partners

Technology and Platforms

Copyright © 2025 Clear View Enterprises LLC